Most breast cancers that occur in women with germline BRCA1 mutations are estrogen receptor-negative (ER-) and typically lack expression of progesterone receptor (PR) and human epidermal growth factor receptor (HER) 2 overexpression (so-called 'triple-negative' breast cancers) [1-8]. The gene discussed is PGR; the disease is breast carcinoma.